glp 1 papillary thyroid cancer Glucagon-Like Peptide-1 Receptor Agonists and Cancer: A Narrative Review Study Assuages Thyroid Cancer Fears

Understanding Loose Skin: What Causes It and How to Address It When I talk to people about their weight loss goals, they usually tell me they want to be healthier, be more active, or look better in their clothes

5 BaeC.SongJ

Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy

Research Diets, Inc

Open communication with your provider about emerging symptoms ensures prompt intervention and treatment modification

The study, published Monday in the journal Nature Medicine, is one of the first big-picture looks at the benefits and risks of these new drugs, which rapidly made an impact on health care, insurance coverage, the grocery industry, and even the economy of an entire country (Denmark, where Novo Nordisk, the maker of Ozempic and Wegovy is based.) These drugs have also been given partial credit for a recent dip in obesity rates in the US, which dropped in 2023 for the first time in over a decade